Get startedLog in
    Picture of Sam-A Pharm Co logo

    009300 — Sam-A Pharm Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,39211,91221,37422,08012,940
    Depreciation
    Amortisation
    Non-Cash Items2,8336,5162,2792,669-1,926
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital3,019-2,010-6,788-3,767-5,099
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities12,94319,60420,76025,24710,723
    Capital Expenditures-275-239-3,820-6,512-1,779
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-19,521-12,793-16,987-14,899-780
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-19,796-13,032-20,807-21,411-2,559
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-3,670-5,381-112-3,522-11,129
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-10,4111,191-156532-2,970